Securities ▲▼ | Shares | Value ($K) | |||||
|---|---|---|---|---|---|---|---|
Q3 2024 ▲▼ | Q4 2024 ▲▼ | Change ▲▼ | Q3 2024 ▲▼ | Q4 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| VERVE THERAPEUTICS, INC. | 2,008,809 | 2,008,809 | 0 | 9,723 | 11,330 | 4.92% | +1,607 |
| SINGULAR GENOMICS SYSTEMS, INC. | 126,630 | 126,630 | 0 | 1,984 | 2,460 | 1.07% | +476 |
| CERO THERAPEUTICS HOLDINGS, INC. | 1,444,296 | 9,393,561 | +7,949,265 | 135 | 564 | 0.24% | +429 |
| UNITY BIOTECHNOLOGY, INC. | 1,004,817 | 1,004,817 | 0 | 1,477 | 981 | 0.43% | -496 |
| GOSSAMER BIO, INC. | 8,055,916 | 8,055,916 | 0 | 7,946 | 7,287 | 3.17% | -659 |
| ERASCA, INC.(ERAS) | 11,055,554 | 11,055,554 | 0 | 30,182 | 27,749 | 12.05% | -2,432 |
| BEAM THERAPEUTICS INC.(BEAM) | 4,834,653 | 4,540,132 | -294,521 | 118,449 | 112,595 | 48.91% | -5,854 |
| RAPPORT THERAPEUTICS, INC.(RAPP) | 3,728,738 | 3,728,738 | 0 | 76,365 | 66,148 | 28.73% | -10,217 |
| Q32 BIO INC. | 320,482 | 320,482 | 0 | 14,300 | 1,102 | 0.48% | -13,197 |